Study of 5-Fluorouracil/Leucovorin/Oxaliplatin (FOLFOX) + Bevacizumab Versus 5-Fluorouracil/Leucovorin/Oxaliplatin/Irinotecan (FOLFOXIRI) + Bevacizumab as First Line Treatment of Patients With Metastatic Colorectal Cancer Not Previously Treated and With Three or More Circulating Tumoral Cells

Clinical trial NCT01640405 · COMPLETED

Trial details

NCT number: NCT01640405
Sponsor: Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD)
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Metastatic Colorectal Cancer

Start date: 2012-07-01
Primary completion: 2018-11-01
Enrollment: 350

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.